Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Clinical trial NCT06121180 · RECRUITING
Trial details
- NCT number
- NCT06121180
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2030-10-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.